Sign in

CIK 0001472091

  • Non-accelerated filer
  • Smaller reporting company

PDS Biotechnology Corp

Sign in to watch
Ticker
PDSB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
264231384
Phone
+1 800-208-3343
Business address
303A COLLEGE ROAD EAST, PRINCETON, NJ, 08540
Former names
Edge Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 27 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-02-14 Saik Andrew Chief Financial Officer Grant or award +38,400 $1.30 $50K 42,549
2019-06-06 Saik Andrew Chief Financial Officer Grant or award · Stock Option (Right To Purchase) +62,715 62,715
2019-03-15 Saik Andrew Chief Financial Officer Option exercise +82,999 82,999
2019-03-15 Saik Andrew Chief Financial Officer Option exercise · Restricted Stock Units −82,999 0
2018-08-14 Saik Andrew Chief Financial Officer Grant or award · Restricted Stock Units +82,999 82,999
2018-06-19 Saik Andrew Chief Financial Officer Grant or award · Stock Option (Right To Purchase) +166,001 166,001
2018-03-01 Saik Andrew Chief Financial Officer Grant or award · Stock Option (Right To Purchase) +50,000 50,000
2017-11-01 Saik Andrew Chief Financial Officer Grant or award · Stock Option (Right To Purchase) +200,000 200,000

Page 1 of 1 · 8 trades